These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 52890)

  • 1. H-2 private specificity of in vivo-sensitized lymphocytes studied by adsorption on fibroblast monolayers.
    Jorgensen PN; Güttler F; Rubin B
    Scand J Immunol; 1975; 4(4):383-9. PubMed ID: 52890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incompatibility at irrelevant H-2 specificities augments in vivo stimulation of alloaggressive cells.
    Jorgensen PN
    Scand J Immunol; 1975; 4(4):373-82. PubMed ID: 52889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective reaction of effector lymphocytes of transplantation immunity to private specificities of the H-2K and H-2D loci.
    Brondz BD; Egorov IK
    Bull Exp Biol Med; 1974 Dec; 77(6):659-62. PubMed ID: 4140743
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 5. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.
    Brondz BD; Egorov IK; Drizlikh GI
    J Exp Med; 1975 Jan; 141(1):11-26. PubMed ID: 46906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;
    Zinkernagel RM; Doherty PC
    J Exp Med; 1975 Jun; 141(6):1427-36. PubMed ID: 47901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes.
    Golstein P; Erik MD; Svedmyr AJ; Wigzell H
    J Exp Med; 1971 Dec; 134(6):1385-402. PubMed ID: 5001703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characteristics of T cell receptors during sensitization against histocompatibility antigens in vitro.
    Kimura AK; Clark WR
    Cell Immunol; 1974 Apr; 12(1):127-39. PubMed ID: 4282067
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
    Ritter J; Lohmann-Matthes ML; Fischer H
    Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuously proliferating T killer cells specific for H-2b targets: selection and characterization.
    Dennert G; De Rose M
    J Immunol; 1976 Jun; 116(6):1601-6. PubMed ID: 58039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxicity of specifically sensitized lymphocytes from mouse strains of varying H-2 specificities on LCM virus-infected L cells.
    Marker O; Andersen GT
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):447-54. PubMed ID: 1087102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytotoxic lymphocytes after allostimulation in vivo: kinetic, reproducibility and specificity after primary stimulation (author's transl)].
    Schulze HA; Brock J; Siegl E; Günther J
    Allerg Immunol (Leipz); 1980; 26(4):310-8. PubMed ID: 6452040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of a subpopulation of T cells bearing histamine receptors.
    Plaut M; Lichtenstein LM; Henney CS
    J Clin Invest; 1975 Apr; 55(4):856-74. PubMed ID: 164483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross reactivity between H-2K and H-2D products. III. Effect of H-2K-H-2D cross sensitization on skin graft survival.
    Murphy DB; Shreffler DC
    Transplantation; 1975 Jul; 20(1):38-44. PubMed ID: 52220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.